Vivanza Biosciences Ltd — Important, 11-11-2025: Company Update

Vivanza Biosciences has announced it is not required to submit the Disclosure of Related Party Transactions for the quarter and half-year ended 30th September, 2025. This is because its paid-up equity share capital and net worth are below specific thresholds. As of 31st March, 2025, the company's paid-up equity capital was ₹4 Cr and net worth was ₹4.02 Cr, both falling below the ₹10 Cr and ₹25 Cr limits for this regulatory filing. The company confirmed it will comply with these requirements if they become applicable in the future.